Researchers have provided new insight into the cellular processes behind the 'shock and kill' approach to curing HIV, which they say challenges the effectiveness of the treatment. Their study, published in the journal eLife, suggests the need to explore alternative treatment strategies against HIV -- a virus which 36.7 million people globally were living with in 2016, with 1.8 million people becoming newly infected in the same year, according to figures from UNAIDS.… read more
For more than 20 years, scientists at Scripps Research have chipped away at the challenges of designing an HIV vaccine. Now new research, published in Immunity, shows that their experimental vaccine strategy works in non-human primates.
The new study shows that rhesus macaque monkeys can be prompted to produce neutralizing antibodies against one strain of HIV that resembles the resilient viral form that most commonly infects people, called a Tier 2 virus. The research also provides the… read more
This article exceeds the 3000 character cap on this page, by the web designers for myHIVteam - but here is the link to read all about this exciting news from the Scripps Research Institure:
Infectious disease specialist, molecular epidemiologist and is the director of the Institute of Molecular Biology and Biotechnology at the National Institutes of Health at the University of the Philippines in Manila.
This site limits detail characters to 3000 - so I will just post the link for you to read.
I hope this discovery helps lead science closer to a cure.
A structural model of viperin a naturally occurring enzyme in humans that is known to have antiviral effects on viruses such as West Nile, hepatitis C, rabies, and HIV. A new study led by researchers from Penn State and the Albert Einstein College of Medicine reveals the… read more
This was black boxed years again terrible drug
DATE: August 27, 2018
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity. A new study by Boston University School of Medicine (BUSM) researchers suggests that use of HIV RNA expression inhibitors as adjunct therapy might diminish atypical inflammation and restore immune function in HIV-infected individuals… read more
This site limits details to 3000 characters. So, I will just post a link to some important relevations about the greedy intentions of Mylan with respect to HIV Generics.
Read and know thy enemy.
I was just wondering if anyone else works in the health care field, specifically surgical areas or sterile processing. If you do have you had any problems with your organization while working? I am getting ready to return to work, hopefully after being off for the past 2.5 years recovering from cryptococcal meningitis. Let me know what your have experienced.
We never share your personal information with anyone.Continue with Facebook Sign up with your email